.png){kind=logo}
Key Takeaways
JB Chemicals share price fell 6.63% with a day low of ₹1,673.00 after Torrent Pharma's acquisition news.
Torrent is buying 46.39% of JB Chemicals at ₹1,600/share, valuing the firm at ₹25,689 crore.
JB Chemicals recorded a 5-year profit CAGR of 21%, ROE of 20.8%, and is nearly debt-free.
JB Chemicals share price fell 6.63% to ₹1,681.30 as of 11:32 AM on June 30, 2025. The decline follows news of Torrent Pharma acquiring a controlling stake in the company.
The stock opened at ₹1,705.00, compared to the previous close of ₹1,801.40. It moved between a high of ₹1,705.00 and a low of ₹1,673.00. The share price is still above its 52-week low of ₹1,385.75, but well below its 52-week high of ₹2,030.00.
Volume surged to 734,923 shares, over four times the 20-day average of 176,155. The VWAP stood at ₹1,689.37, indicating consistent selling pressure. The company’s market cap now stands at ₹26,249 crore.
The JB Chemicals share price chart shows a drop of 6.62% as of 11.45 AM:
For FY25, JB Chemicals reported:
Turnover: ₹3,918 crore
Net Worth: ₹3,433 crore
ROE: 20.8%
ROCE: 26.6%
TTM EPS: ₹42.26 (up 18.69% YoY)
Dividend Yield: 0.92%
The stock has a TTM PE of 39.80, slightly above the sector PE of 38.88, and a P/B ratio of 8.18. Despite today's fall, it has posted a 5-year stock price CAGR of 39%.
Also Read: Jio Financial Share Price Jumps 3.98% to ₹324.95 After SEBI Approval
Torrent Pharma plans to acquire 46.39% of JB Chemicals from Tau Investment Holdings at ₹1,600 per share. It may buy another 2.8% from employees and has proposed an open offer of ₹1,639.18/share for up to 26% of expanded capital. This gives JB Chemicals a total equity valuation of ₹25,689 crore.
The deal needs approvals from the CCI, shareholders, and other regulatory bodies. The latter expects to complete the acquisition in six months. Interestingly, while JB Chemicals declined sharply, Torrent Pharma’s shares rose 3.7% to ₹3,344.40.
JB Chemicals has 350+ products, including Cilacar, Azmarda, Apradom, and Aqua Plus. It is strong in chronic therapy segments and has expanded into ophthalmology.
For Torrent, this acquisition boosts its chronic portfolio and brings new specialty segments. The company is expected to benefit from operational synergies and market share expansion.
Also Read: Best Performing Stocks in June 2025: Your Investment Guide
1. What is JB Chemicals' share price today?
It is ₹1,681.30 as of 11:32 AM on June 30, 2025.
2. Why did JB Chemicals' stock fall today?
The share price dropped after Torrent Pharma announced a controlling stake acquisition at ₹1,600/share.
3. What is the valuation of the Torrent Pharma acquisition deal?
The equity valuation of JB Chemicals stands at approximately ₹25,689 crore.
4. What is JB Chemicals' 5-year stock CAGR?
It has delivered a 5-year stock CAGR of 39%.
5. Is JB Chemicals a debt-free company?
Yes, JB Chemicals is nearly debt-free and maintains strong financials.
